Meduslabs — Evidence-based health research
Home›Cholesterol›How to Lower LDL (Bad) Cholesterol Naturally
Key Takeaways

Lowering bad (LDL) cholesterol

Cholesterol takes part in many essential body functions; it is a building material produced by our liver. Two types of cholesterol circulate in the body, but only one needs to be watched closely — LDL, the "bad" cholesterol.

What drives the build-up of bad cholesterol in the blood?

An unhealthy diet is the main cause of high LDL cholesterol. Another risk factor is certain diseases and the drugs taken for them, as well as smoking, obesity and chronic inflammation. Crucially, the body overproduces LDL largely in response to inflammation — and the biggest dietary driver of inflammation is sugar.

Lowering LDL with soluble fibre

Fibre is a substance the stomach does not digest, or digests only partly and slowly. Soluble fibre (found in vegetables, oats, legumes) dissolves in water and helps the body remove excess cholesterol, lowering LDL. Insoluble fibre supports digestion. Get fibre from whole foods rather than supplements.

What are hydrogenated fats, and lowering LDL by avoiding them

Hydrogenated (trans) unsaturated fats form when vegetable oils are chemically altered to stay solid at room temperature, which greatly extends shelf life. Research has shown a direct link between hydrogenated fats and cardiovascular disease, breast cancer, infant nervous-system disorders, diabetes, obesity and allergies.5 They directly affect cholesterol too: raising LDL and lowering HDL.6

The benefit of good fats: lowering LDL by eating good fats

If hydrogenated fats are the "poison," then there is an antidote. Monounsaturated and omega-3 fats — olive oil, avocado, wild fatty fish, nuts — help lower LDL and reduce inflammation, improving the overall balance.

Lowering LDL with exercise — the benefit of physical activity

At least 150 minutes of moderate-intensity physical activity per week, such as brisk walking, helps LDL begin to fall while raising HDL and reducing inflammation.

Lowering LDL by resisting the temptation of sugar

Sugar is the main dietary driver of inflammation, and inflammation is what makes the body overproduce cholesterol. Cutting sugar and refined carbohydrates addresses the cause of high LDL, not just the symptom.

How to quickly and easily lower bad cholesterol?

Research shows mushroom polysaccharides can lower cholesterol with effectiveness similar to statins, without the side effects — using a concentrated, multi-extract formula rather than simple powders.

Related supplement

Research suggests mushroom polysaccharides lower LDL similarly to statins without side effects. A concentrated multi-extract formula is essential.

AURI 25 by Zenius Labs™ →
Can diet alone lower bad cholesterol?

Yes — dietary change is one of the most effective approaches: adding more fibre-rich foods such as oats or legumes helps the body naturally remove excess cholesterol. The best results come from combining a healthy diet with regular physical activity.

How much exercise is needed for LDL to start falling?

At least 150 minutes of moderate-intensity activity per week, such as brisk walking, is recommended. This helps lower LDL while raising HDL and reducing inflammation.

What raises bad (LDL) cholesterol the most?

An unhealthy diet is the main cause — especially sugar and refined carbohydrates (which drive inflammation) and hydrogenated (trans) fats, which directly raise LDL and lower HDL. Certain diseases and medications also contribute.

Can bad cholesterol be lowered without statins?

Research shows mushroom polysaccharides can lower cholesterol similarly to statins without side effects. This requires a concentrated multi-extract formula such as AURI 25 by Zenius Labs™, not simple powders.

References
  1. PMC3614039. PMC
  2. PMC3551118. PMC
  3. PMC2830458. PMC
  4. Research reference — who.int. Who
  5. Research reference — medlineplus.gov. Medlineplus
  1. Research reference — priklausomi.lt. Priklausomi
  2. Research reference — lancastergeneralhealth.org. Lancastergeneralhealth
  3. Research reference — sciencedirect.com. Sciencedirect
  4. Research reference — journals.plos.org. Journals
  5. Halbert SC et al. Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. The American journal of cardiology. 2010. PubMed
  6. Brown AS et al. Statin Intolerance. Reviews in cardiovascular medicine. 2018. PubMed
  7. Riaz H et al. Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance. The American journal of cardiology. 2017. PubMed
  8. Ahmad K et al. Effectiveness of Coenzyme Q10 Supplementation in Statin-Induced Myopathy: A Systematic Review. Cureus. 2024. PubMed
  9. Fitzgerald K et al. Statin-induced Myopathy. Global advances in health and medicine. 2012. PubMed
  10. Gong J et al. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials. Molecular nutrition & food research. 2018. PubMed
  11. Chen JT et al. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy. 2005. PubMed
  12. Millán J et al. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. 2016. PubMed
  13. Singh DK et al. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. The Journal of pharmacology and experimental therapeutics. 2006. PubMed
  14. Castaño G et al. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clinical drug investigation. 2003. PubMed
  15. Xiong Z et al. An overview of the bioactivity of monacolin K / lovastatin. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2019. PubMed
  16. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) et al. Scientific Opinion on additional scientific data related to the safety of monacolins from red yeast rice submitted pursuant to Article 8(4) of Regulation (EC) No 1925/2006. EFSA journal. European Food Safety Authority. 2025. PubMed
  17. Angelopoulos N et al. Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial. Nutrients. 2023. PubMed
  18. Trimarco B et al. Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet. Mediterranean journal of nutrition and metabolism. 2011. PubMed
  19. González-Bonilla A et al. Dietary Supplementation with Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Reduces Visceral Fat and Hyperlipidemia in Inhabitants of a Rural Community in Mexico. International journal of medicinal mushrooms. 2022. PubMed
  20. Abrams DI et al. Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC complementary and alternative medicine. 2011. PubMed
  21. Zhang Y et al. Pleurotus abieticola Polysaccharide Alleviates Hyperlipidemia Symptoms via Inhibition of Nuclear Factor-κB/Signal Transducer and Activator of Transcription 3-Mediated Inflammatory Responses. Nutrients. 2023. PubMed
  22. Du H et al. Dietary intake of whole king oyster mushroom (Pleurotus eryngii) attenuated obesity via ameliorating lipid metabolism and alleviating gut microbiota dysbiosis. Food research international (Ottawa, Ont.). 2024. PubMed
  23. Yoon SJ et al. The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin. Thrombosis research. 2003. PubMed
  24. Bian C et al. A Novel Polysaccharide from AuriculariaAuricula Alleviates Thrombosis Induced by Carrageenan in Mice. Molecules (Basel, Switzerland). 2022. PubMed
  25. Shi Q et al. Isolation, Characterization, and Antioxidant Activity of Melanin from Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms. 2023. PubMed
  26. Yin CM et al. Physicochemical Properties and Antioxidant Activity of Natural Melanin Extracted from the Wild Wood Ear Mushroom, Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms. 2022. PubMed
  27. Liu X et al. Comprehensive utilization of edible mushroom Auricularia auricula waste residue-Extraction, physicochemical properties of melanin and its antioxidant activity. Food science & nutrition. 2019. PubMed
  28. Pirro M et al. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials. Pharmacological research. 2016. PubMed
  29. Iskandar I et al. Efficacy and tolerability of a nutraceutical combination of red yeast rice, guggulipid, and chromium picolinate evaluated in a randomized, placebo-controlled, double-blind study. Complementary therapies in medicine. 2020. PubMed
  30. Garoufi A et al. Beneficial Effects of a Nutraceutical Combination on Lipid Profiles in Children with Moderate and Severe Hypercholesterolemia. Biomolecules. 2024. PubMed
  31. Protic O et al. Nutraceutical Combinations in Hypercholesterolemia: Evidence from Randomized, Placebo-Controlled Clinical Trials. Nutrients. 2021. PubMed
  32. Trimarco V et al. Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension. 2015. PubMed
  33. Hoogeveen RC et al. Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation. Clinical chemistry. 2021. PubMed
  34. Bashir B et al. Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia. Frontiers in cardiovascular medicine. 2024. PubMed
  35. Soran H et al. Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk. Atherosclerosis. 2018. PubMed
  36. Chapman MJ Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease. Pharmacology & therapeutics. 2006. PubMed
Zenius Labs™

AURI 25 - multi-pathway cholesterol formula

AURI 25 by Zenius Labs\u2122 combines Auricularia auricula-judae and Pleurotus ostreatus mushroom extracts, policosanol, and monacolin K - four complementary pathways studied for lowering LDL, rather than a single ingredient.

Discover AURI 25